The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

HPV vaccinations could eliminate cervical cancer, researchers say

| July 9, 2019

The success of the HPV vaccination offers hope of one day eradicating cervical cancer, say scientists who carried out a major review of evidence.

Vaccination against the human papilloma virus, which causes most cervical cancers, began over a decade ago.

A Lancet review of 65 studies covering 60 million people showed a fall in HPV cases and in pre-cancerous growths.

Over decades, this should translate into a significant fall, and possible eradication, of the cancer they said.

The review covered studies in 14 high-income countries, including the UK. They looked at HPV rates, plus cases of genital warts and pre-cancerous cells in the cervix called CIN.

It found that when rates were compared before vaccination started and eight years after:

  • Cases of HPV 16 and 18 were down 83% in girls aged 15-19 – 66% in women 20-24
  • Genital warts cases fell 67% in girls 15-19 – 54% in women 20-24
  • Pre-cancerous growths were down by 51% in girls 15-19 – 31% in women 20-24

It also showed people who were not vaccinated benefited. Cases of genital warts in boys aged 15-19 fell by almost 50%, and also significantly in women over 30.

[Researcher Marc Brisson] said cervical cancer elimination – defined as fewer than four cases per 100,000 – “might be possible if sufficiently high vaccination coverage can be achieved and maintained”.

Read full, original post: Hopes raised of cervical cancer eradication

Related article:  Podcast: Should you get your entire genome sequenced? The pros and cons of diving into your DNA
The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend